3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
22
INDUSTRY
11
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
icotinib
2
Erlotinib Hydrochloride
2
pembrolizumab
1
camrelizumab
1
aumolertinib
1
apatinib
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pemetrexed
1
Gemcitabine
1
Gefitinib
1
Drug Therapy
1
Cisplatin
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Carcinoma, Non-Small-Cell Lung
×
aumolertinib
×
Clear all
NCT04762459
2022-02-24
APEX
ChineseAMS
Phase 3
Enrolling by invitation
606 enrolled